Xenetic Biosciences, Inc. / Fundamentals
Income statement
- Net revenue
€2.11M - Cost of goods sold
€0.00 - Gross profit
€1.60M - SG&A expenses
€2.39M - R&D expenses
€2.54M - EBITDA
-€2.82M - D&A
€0.00 - EBIT
-€2.82M - Interest expenses
€0.00 - EBT
-€2.66M - Tax expenses
€0.00 - Net income
-€2.66M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€147.74K - Changes in working capital
€263.67K - Operating cash flow
-€2.17M - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
€0.00 - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
€0.00 - Net financing cash flow
€0.00 - Foreign exchange effects
€0.00 - Net change in cash
-€2.17M - Cash at end of period
€4.13M - Free cash flow
-€2.17M
Balance sheet
- Cash and cash equivalents
€4.13M - Cash and short-term investments
€4.13M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€495.26K - Total current assets
€4.62M - Property, plant & equipment
€0.00 - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€0.00 - Total assets
€4.62M - Accounts payable
€299.33K - Short-term debt
€0.00 - Other current liabilities
€480.37K - Total current liabilities
€779.69K - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€0.00 - Total liabilities
€779.69K - Common stock
€1.33K - Retained earnings
-€171.56M - Other equity
€218.98K - Total equity
€3.84M - Total liabilities and shareholders' equity
€4.62M
Company information
- Market capitalization
€4.64M - Employees
2 - Enterprise Value
-€521.84K
Company ratios
- Gross margin
-
75.9% Much better than peer group: -11,757,934,180,052,603,000.0% - EBITDA margin
-
-133.5% Much better than peer group: -1,135,307,296,018,323,000.0% - EBIT margin
-
-133.5% Much better than peer group: -973,485,429,495,931,600.0% - EBT margin
-
-126.0% Much better than peer group: -1,189,653,254,496,154,600.0% - Net margin
-
-126.0% Much better than peer group: -1,189,653,254,496,150,600.0% - ROE
-
-69.3% Much better than peer group: -168.9% - ROA
-
-57.6% Much better than peer group: -285.0% - Asset turnover
-
45.7% Better than peer group: 38.1% - FCF margin
-
-103.0% Much better than peer group: -673,930,037,162,521,800.0% - FCF yield
-46.8% - Efficiency ratio
233.5% - Net sales per employee
-
€1.06M - Net income per employee
-
-€1.33M